Methods and compositions for treating genetically linked diseases of the eye

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9873893
SERIAL NO

14766842

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Expression vectors and therapeutic methods of using such vectors in the treatment of diseases of the eye resulting from failure to produce a specific protein in the eye, or the production of a non-functional protein in the eye.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICESOFFICE OF TECH TRANSFER NIH 6011 EXECUTIVE BLVD SUITE 325 MSC 7660 BETHESDA MD 20892-7660

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bush, Ronald Avery Gaithersburg, US 3 2
Colosi, Peter C San Anselmo, US 23 402
Sieving, Paul Albert Bethesda, US 3 2
Zeng, Yong Potomac, US 43 125

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 23, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 23, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00